Trade Perrigo - PRGO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.17 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 28.43 |
| Open | 28.03 |
| 1-Year Change | -10.19% |
| Day's Range | 27.86 - 28.17 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 21, 2025 | 27.88 | -0.10 | -0.36% | 27.98 | 28.25 | 27.74 |
| Mar 20, 2025 | 28.43 | 0.95 | 3.46% | 27.48 | 28.57 | 27.41 |
| Mar 19, 2025 | 27.83 | -0.02 | -0.07% | 27.85 | 28.09 | 27.52 |
| Mar 18, 2025 | 27.80 | -0.12 | -0.43% | 27.92 | 28.98 | 27.68 |
| Mar 17, 2025 | 28.21 | 1.20 | 4.44% | 27.01 | 28.51 | 27.01 |
| Mar 14, 2025 | 27.20 | 0.58 | 2.18% | 26.62 | 27.25 | 26.46 |
| Mar 13, 2025 | 26.67 | -0.51 | -1.88% | 27.18 | 27.53 | 26.67 |
| Mar 12, 2025 | 27.43 | -0.07 | -0.25% | 27.50 | 27.89 | 27.24 |
| Mar 11, 2025 | 27.80 | 0.65 | 2.39% | 27.15 | 28.08 | 26.90 |
| Mar 10, 2025 | 27.37 | -0.06 | -0.22% | 27.43 | 27.99 | 27.26 |
| Mar 7, 2025 | 27.63 | -0.41 | -1.46% | 28.04 | 28.45 | 27.57 |
| Mar 6, 2025 | 28.57 | -0.44 | -1.52% | 29.01 | 29.22 | 28.38 |
| Mar 5, 2025 | 29.40 | 0.41 | 1.41% | 28.99 | 29.47 | 28.68 |
| Mar 4, 2025 | 29.67 | 0.95 | 3.31% | 28.72 | 29.73 | 28.61 |
| Mar 3, 2025 | 28.93 | -0.29 | -0.99% | 29.22 | 30.85 | 28.64 |
| Feb 28, 2025 | 28.80 | 1.33 | 4.84% | 27.47 | 29.45 | 27.04 |
| Feb 27, 2025 | 24.01 | -0.56 | -2.28% | 24.57 | 25.22 | 23.92 |
| Feb 26, 2025 | 24.84 | -0.22 | -0.88% | 25.06 | 25.32 | 24.69 |
| Feb 25, 2025 | 25.07 | -0.18 | -0.71% | 25.25 | 25.51 | 24.94 |
| Feb 24, 2025 | 25.17 | -0.05 | -0.20% | 25.22 | 25.55 | 24.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Perrigo Company profile
About Perrigo Company PLC
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S) and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies, and e-commerce channels.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Perrigo Company PLC revenues increased 1% to $4.14B. Net loss before extraordinary items totaled $130.9M vs. income of $44.2M. Revenues reflect CSCI segment increase of 4% to $1.45B, CSCA segment remaining flat at $2.69B, Europe segment increase of 3% to $1.39B. Net loss reflects CSCA segment income decrease of 56% to $206.5M. Dividend per share increased from $0.90 to $0.96.
Equity composition
Common Stock no Par, 08/11, 200M auth., 92,797,375 issd. Insiders own 7.05%. IPO: 10/93, 13Mshares @ $31 by J.P. Morgan Securities Inc. 8/93, 2-for-1 stock split. FY'02 & Q's are restated. FY'03 & '04 Summ. Q's reflect the reclassification. FY'04 Q's are reclassified.
| Industry: | Pharmaceuticals (NEC) |
The Sharp Building
Hogan Place
DUBLIN
DUBLIN
IE
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 700,000+ traders worldwide that chose to trade with Capital.com